GDC 172 (Qc pink bismuth 262 mg)
Pill imprint GDC 172 has been identified as Qc pink bismuth 262 mg.
Bismuth subsalicylate is used in the treatment of helicobacter pylori infection; diarrhea, chronic; diarrhea; traveler's diarrhea; indigestion (and more), and belongs to the drug class antidiarrheals. FDA has not classified the drug for risk during pregnancy. Bismuth subsalicylate 262 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- GDC 172
- Strength:
- 262 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Antidiarrheals
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Chain Drug Marketing Association
More about bismuth subsalicylate
Consumer resources
- Bismuth subsalicylate
- Bismuth subsalicylate chewable tablets
- Bismuth subsalicylate suspension
- Bismuth subsalicylate (Advanced Reading)
- Other brands: Pepto-Bismol, Kaopectate, Bismatrol, Pink Bismuth, More (6) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
